GJB5
geneOn this page
Also known as CX31.1
Summary
GJB5 (gap junction protein beta 5, HGNC:4287) is a protein-coding gene on chromosome 1p34.3, encoding Gap junction beta-5 protein (O95377). One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
This gene encodes a member of the beta-type (group I) connexin family. The encoded protein is a gap junction protein involved in intercellular communication related to epidermal differentiation and environmental sensing. This gene has been linked to non-small cell lung cancer.
Source: NCBI Gene 2709 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_005268
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4287 |
| Approved symbol | GJB5 |
| Name | gap junction protein beta 5 |
| Location | 1p34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CX31.1 |
| Ensembl gene | ENSG00000189280 |
| Ensembl biotype | protein_coding |
| OMIM | 604493 |
| Entrez | 2709 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000338513, ENST00000863284, ENST00000915003
RefSeq mRNA: 1 — MANE Select: NM_005268
NM_005268
CCDS: CCDS382
Canonical transcript exons
ENST00000338513 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001368006 | 34755047 | 34755195 |
| ENSE00001377830 | 34757307 | 34758512 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 95.45.
FANTOM5 (CAGE): breadth broad, TPM avg 3.3523 / max 138.1978, expressed in 227 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2070 | 3.0661 | 217 |
| 2071 | 0.2863 | 89 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 95.45 | gold quality |
| skin of abdomen | UBERON:0001416 | 95.19 | gold quality |
| esophagus mucosa | UBERON:0002469 | 94.95 | gold quality |
| skin of leg | UBERON:0001511 | 94.58 | gold quality |
| zone of skin | UBERON:0000014 | 93.02 | gold quality |
| upper arm skin | UBERON:0004263 | 90.87 | gold quality |
| upper leg skin | UBERON:0004262 | 88.62 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 88.30 | silver quality |
| gingiva | UBERON:0001828 | 88.13 | gold quality |
| gingival epithelium | UBERON:0001949 | 87.62 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 87.19 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 86.76 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.10 | gold quality |
| oral cavity | UBERON:0000167 | 85.49 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 82.36 | gold quality |
| squamous epithelium | UBERON:0006914 | 82.24 | gold quality |
| vagina | UBERON:0000996 | 81.79 | gold quality |
| mammalian vulva | UBERON:0000997 | 81.08 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 79.62 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.76 | silver quality |
| cervix epithelium | UBERON:0004801 | 77.32 | gold quality |
| nipple | UBERON:0002030 | 75.53 | gold quality |
| penis | UBERON:0000989 | 75.51 | gold quality |
| mouth mucosa | UBERON:0003729 | 74.31 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 73.72 | gold quality |
| minor salivary gland | UBERON:0001830 | 72.24 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 71.34 | silver quality |
| gall bladder | UBERON:0002110 | 71.02 | gold quality |
| esophagus | UBERON:0001043 | 70.98 | gold quality |
| skin of hip | UBERON:0001554 | 69.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.35 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting GJB5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-1224-5P | 99.48 | 65.59 | 803 |
| HSA-MIR-219A-1-3P | 98.91 | 67.87 | 639 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-4712-3P | 98.52 | 65.39 | 822 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-22-5P | 97.67 | 68.92 | 1355 |
| HSA-MIR-4723-3P | 97.67 | 65.91 | 1017 |
| HSA-MIR-500A-3P | 97.60 | 67.48 | 595 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-6769B-3P | 97.41 | 65.53 | 1036 |
| HSA-MIR-3183 | 97.40 | 65.68 | 978 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
Literature-anchored findings (GeneRIF, showing 4)
- Overexpression of Cx31.1 in H1299 cells reduced cell proliferation, delayed the G1 phase, inhibited anchorage-independent growth, and suppressed cell migration and invasion. Xenografts of Cx31.1 overexpressing H1299 cells had reduced tumourigenicity. (PMID:21777377)
- autophagy contributed to Cx31.1 degradation, and clathrin might be involved in the autophagy of Cx31.1. (PMID:25388970)
- GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma. (PMID:34240406)
- Cx31.1 can selectively intermix with co-expressed connexins to facilitate its assembly into gap junctions. (PMID:38533727)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gjb10 | ENSDARG00000075854 |
| mus_musculus | Gjb5 | ENSMUSG00000042357 |
| rattus_norvegicus | Gjb5 | ENSRNOG00000059897 |
Paralogs (20): GJA8 (ENSG00000121634), GJB6 (ENSG00000121742), GJA3 (ENSG00000121743), GJA9 (ENSG00000131233), GJA10 (ENSG00000135355), GJA1 (ENSG00000152661), GJD2 (ENSG00000159248), GJB7 (ENSG00000164411), GJB2 (ENSG00000165474), GJB1 (ENSG00000169562), GJC3 (ENSG00000176402), GJD4 (ENSG00000177291), GJC1 (ENSG00000182963), GJD3 (ENSG00000183153), GJA4 (ENSG00000187513), GJB3 (ENSG00000188910), GJB4 (ENSG00000189433), GJC2 (ENSG00000198835), GJE1 (ENSG00000203733), GJA5 (ENSG00000265107)
Protein
Protein identifiers
Gap junction beta-5 protein — O95377 (reviewed: O95377)
Alternative names: Connexin-31.1
All UniProt accessions (2): A0A654IE64, O95377
UniProt curated annotations — full annotation on UniProt →
Function. One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
Subunit / interactions. A connexon is composed of a hexamer of connexins.
Subcellular location. Cell membrane. Cell junction. Gap junction.
Similarity. Belongs to the connexin family. Beta-type (group I) subfamily.
RefSeq proteins (1): NP_005259* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000500 | Connexin | Family |
| IPR002271 | Connexin311 | Family |
| IPR013092 | Connexin_N | Domain |
| IPR017990 | Connexin_CS | Conserved_site |
| IPR019570 | Connexin_CCC | Domain |
| IPR038359 | Connexin_N_sf | Homologous_superfamily |
Pfam: PF00029
UniProt features (10 total): topological domain 5, transmembrane region 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95377-F1 | 78.61 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-190861 | Gap junction assembly |
MSigDB gene sets: 157 (showing top):
GOBP_LABYRINTHINE_LAYER_DEVELOPMENT, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, MORF_FLT1, MORF_MSH3, MODULE_45, MORF_BRCA1, RIZKI_TUMOR_INVASIVENESS_3D_DN, REACTOME_MEMBRANE_TRAFFICKING, MORF_ESR1, MODULE_16, MORF_RAD51L3, GOBP_CELL_CELL_SIGNALING, BILD_HRAS_ONCOGENIC_SIGNATURE, GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT, GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT
GO Biological Process (6): cell-cell signaling (GO:0007267), epidermis development (GO:0008544), trophoblast giant cell differentiation (GO:0060707), labyrinthine layer morphogenesis (GO:0060713), cell communication (GO:0007154), transmembrane transport (GO:0055085)
GO Molecular Function (2): gap junction channel activity (GO:0005243), protein binding (GO:0005515)
GO Cellular Component (5): connexin complex (GO:0005922), plasma membrane (GO:0005886), gap junction (GO:0005921), membrane (GO:0016020), anchoring junction (GO:0070161)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Gap junction trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 2 |
| cell communication | 1 |
| signaling | 1 |
| tissue development | 1 |
| cell differentiation involved in embryonic placenta development | 1 |
| embryonic morphogenesis | 1 |
| embryonic placenta morphogenesis | 1 |
| labyrinthine layer development | 1 |
| transport | 1 |
| wide pore channel activity | 1 |
| binding | 1 |
| gap junction | 1 |
| plasma membrane protein complex | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell-cell junction | 1 |
| cellular anatomical structure | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
404 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GJB5 | CACNA1C | Q13936 | 497 |
| GJB5 | GJE1 | A6NN92 | 458 |
| GJB5 | VSIG1 | Q86XK7 | 434 |
| GJB5 | GOLT1A | Q6ZVE7 | 432 |
| GJB5 | PKP1 | Q13835 | 424 |
| GJB5 | DSG3 | P32926 | 416 |
| GJB5 | FAT2 | Q9NYQ8 | 387 |
| GJB5 | PANX1 | Q96RD7 | 353 |
| GJB5 | JAKMIP2 | Q96AA8 | 335 |
| GJB5 | TP63 | Q9H3D4 | 331 |
| GJB5 | SERPINB13 | Q9UIV8 | 310 |
| GJB5 | CLCA2 | Q9UQC9 | 310 |
| GJB5 | CIMIP2C | A6NJV1 | 307 |
| GJB5 | BHLHE22 | Q8NFJ8 | 304 |
| GJB5 | BTBD7 | Q9P203 | 296 |
IntAct
121 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GJB5 | LPAR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | MIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | FAM3C | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | PLPP4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SEC22B | GJB5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | SERP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | PGAP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | NAPB | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | COMT | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | RPRM | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | AQP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | VSTM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | TMEM86A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | TM4SF4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | SLC41A2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | CTXN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYB5B | GJB5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | TMEM128 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | APOL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | TMEM60 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | TSPO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | SLC38A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | ARLN | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | SEC22A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GJB5 | ERG28 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | PNLIPRP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | TMEM97 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | LRP10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJB5 | RTP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (74): GJB5 (Affinity Capture-Western), CLTC (Affinity Capture-Western), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid), GJB5 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTI8, A6NN92, E9Q9H8, F6RWY9, O18968, O64761, O70610, O75712, O93533, O95377, O95452, P08033, P08034, P08983, P25305, P28230, P28231, P28232, P28233, P36380, P49111, P51916, P70689, P79826, Q02738, Q02739, Q0IIL2, Q13571, Q2KJA5, Q3SZ36, Q3T110, Q3TUD9, Q49LS6, Q4VV71, Q58D78, Q5E9Z5, Q5F410, Q5JW98, Q5REZ0, Q60HF7
Diamond homologs: A2VE67, A4GG66, A4GVD1, A4IFL1, A6XKM2, O18968, O54851, O57474, O70610, O75712, O93533, O95377, O95452, P08033, P08034, P08050, P08983, P14154, P16863, P16864, P17302, P18246, P18860, P18861, P21994, P23242, P25305, P28228, P28229, P28230, P28231, P28232, P28233, P28234, P28235, P28236, P29033, P29414, P29415, P33725
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
322 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:34755193:CAGG:C | donor_loss | 1.0000 |
| 1:34755195:GGTAA:G | donor_loss | 1.0000 |
| 1:34755196:G:GA | donor_loss | 1.0000 |
| 1:34757302:TGCA:T | acceptor_loss | 1.0000 |
| 1:34757303:GCA:G | acceptor_loss | 1.0000 |
| 1:34757305:A:AG | acceptor_gain | 1.0000 |
| 1:34757305:AGTA:A | acceptor_loss | 1.0000 |
| 1:34757306:G:A | acceptor_loss | 1.0000 |
| 1:34757306:G:GA | acceptor_gain | 1.0000 |
| 1:34757306:GT:G | acceptor_gain | 1.0000 |
| 1:34757306:GTA:G | acceptor_gain | 1.0000 |
| 1:34757306:GTAGC:G | acceptor_gain | 1.0000 |
| 1:34755196:G:GG | donor_gain | 0.9900 |
| 1:34755197:T:A | donor_loss | 0.9900 |
| 1:34756097:G:T | donor_gain | 0.9800 |
| 1:34757302:T:TA | acceptor_gain | 0.9800 |
| 1:34755191:CTCAG:C | donor_gain | 0.9700 |
| 1:34757294:T:TA | acceptor_gain | 0.9600 |
| 1:34757303:GCAGT:G | acceptor_gain | 0.9500 |
| 1:34757304:CAGTA:C | acceptor_gain | 0.9500 |
| 1:34757305:AGTAG:A | acceptor_gain | 0.9500 |
| 1:34755192:TCAG:T | donor_gain | 0.9400 |
| 1:34755194:AG:A | donor_gain | 0.9400 |
| 1:34755195:GG:G | donor_gain | 0.9400 |
| 1:34756097:G:GT | donor_gain | 0.9300 |
| 1:34757302:TGCAG:T | acceptor_gain | 0.9200 |
| 1:34757309:GC:G | acceptor_gain | 0.9200 |
| 1:34755193:CAG:C | donor_gain | 0.9000 |
| 1:34757306:G:T | acceptor_gain | 0.9000 |
| 1:34757309:G:GA | acceptor_gain | 0.9000 |
AlphaMissense
1795 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:34757730:A:C | S134R | 0.984 |
| 1:34757732:C:A | S134R | 0.984 |
| 1:34757732:C:G | S134R | 0.984 |
| 1:34757744:G:C | K138N | 0.979 |
| 1:34757744:G:T | K138N | 0.979 |
| 1:34757856:T:C | F176L | 0.979 |
| 1:34757858:C:A | F176L | 0.979 |
| 1:34757858:C:G | F176L | 0.979 |
| 1:34757482:T:G | F51C | 0.977 |
| 1:34757586:T:C | C86R | 0.977 |
| 1:34757487:T:A | C53S | 0.974 |
| 1:34757488:G:C | C53S | 0.974 |
| 1:34757879:G:C | K183N | 0.974 |
| 1:34757879:G:T | K183N | 0.974 |
| 1:34757853:T:A | C175S | 0.973 |
| 1:34757854:G:C | C175S | 0.973 |
| 1:34757855:C:G | C175W | 0.973 |
| 1:34757462:G:C | W44C | 0.972 |
| 1:34757462:G:T | W44C | 0.972 |
| 1:34757508:T:A | C60S | 0.971 |
| 1:34757509:G:C | C60S | 0.971 |
| 1:34757400:T:A | W24R | 0.969 |
| 1:34757400:T:C | W24R | 0.969 |
| 1:34757481:T:C | F51L | 0.969 |
| 1:34757483:C:A | F51L | 0.969 |
| 1:34757483:C:G | F51L | 0.969 |
| 1:34757763:T:C | F145L | 0.969 |
| 1:34757765:T:A | F145L | 0.969 |
| 1:34757765:T:G | F145L | 0.969 |
| 1:34757835:T:A | C169S | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000133756 (1:34753553 C>G), RS1000591147 (1:34756359 G>C), RS1000799738 (1:34756634 G>A), RS1001321641 (1:34753521 A>G), RS1001461932 (1:34758874 G>A), RS1001712898 (1:34756077 T>C), RS1002849825 (1:34755227 C>G,T), RS1003385380 (1:34754977 C>T), RS1004642573 (1:34756232 G>A), RS1006339921 (1:34758218 G>A), RS1007411350 (1:34754230 A>G), RS1007466840 (1:34754596 G>A), RS1008905308 (1:34755285 G>A), RS1009085015 (1:34755584 C>A,T), RS1009140060 (1:34755857 A>G)
Disease associations
OMIM: gene MIM:604493 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001523_14 | Visceral adipose tissue adjusted for BMI | 6.000000e-06 |
| GCST005522_5 | Narcolepsy | 5.000000e-07 |
| GCST007559_2 | Sleep duration (short sleep) | 5.000000e-08 |
| GCST009612_3 | Triglyceride levels x thiazide or thiazide-like diuretics use interaction | 6.000000e-07 |
| GCST012282_1 | BMI x environmental factors (excluding physical activity) interaction | 4.000000e-06 |
| GCST012283_1 | BMI x environmental factors (including physical activity) interaction | 4.000000e-06 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004530 | triglyceride measurement |
| EFO:0006527 | smoking status measurement |
| EFO:0009374 | energy intake measurement |
| EFO:0009695 | household income |
| EFO:0010810 | protein intake measurement |
| EFO:0010811 | carbohydrate intake measurement |
| EFO:0011015 | educational attainment |
| EFO:0008002 | physical activity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: other ic — Connexins and Pannexins
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects splicing, decreases expression | 2 |
| propionaldehyde | increases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Calcium, Carbenoxolone
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): narcolepsy-cataplexy syndrome